Product details
Skin & Tissue
GHK-Cu 50mg
GHK-Cu (Glycyl-L-histidyl-L-lysine bound to copper) is a naturally occurring copper-binding tripeptide. Extensive in-vitro literature on skin remodelling, collagen and elastin synthesis, anti-inflammatory effects, and modulation of gene expression related to wound healing. Each vial is sterile lyophilised powder. HPLC-tested 99%. Cold-chain shipped.
Research notes
Mechanism, dosing reference & cycle guidance for GHK-Cu
Read the research note
Research Reference
Dosing & reconstitution
- Reconstitution
- 50 mg vial: 2 mL BAC → 25 mg/mL. Draw 0.04 mL = 1 mg; 0.08 mL = 2 mg. 100 mg vial: 3 mL BAC → 33.3 mg/mL. Draw 0.03 mL = 1 mg; 0.06 mL = 2 mg.
- Common dose
- 1.0–2.0 mg per day subcutaneous, or 2.0–3.0 mg every other day
- Maintenance
- 0.5–1.0 mg/day for 12+ week extended runs
- Cycle length
- 4–8 weeks standard; 8–12 weeks for active remodelling protocols
Research-reference figures from the published literature. For in-vitro research and laboratory use only.
Currently sold out — use the form below to be notified the moment we restock.
Currently sold out
Notify me when restocked
Drop your email and we’ll let you know the moment GHK-Cu 50mg is back in stock.
Products supplied by AEON are intended for in-vitro research and laboratory use only. They are not approved by the TGA or any other regulatory body for human consumption, therapeutic use, or any clinical application. Information presented on this site references published research and is provided for educational purposes. Nothing on this site constitutes medical advice. Customers are responsible for compliance with all local laws.